ClinicalTrials.gg
Drug

Argatroban clinical trials

Also written Novastan.

studies test it
23
open now
1
in phase 3
4
first study started
2002

How each study uses argatroban is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the argatroban studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
30 Jun 2000 · ARGATROBAN · NDA 020883 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Argatroban
20
Argatra
2

Brand

Novastan
2

Studies by the year they started

23 studies that test it; most in 2010 (3)

Studies that test argatroban, by start year
YearStudies
20021
20032
20052
20092
20103
20111
20121
20151
20161
20171
20182
20191
20202
20212
20241

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
7
Phase 3
4
Phase 4
12
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 5 · Other 18

Tanabe Pharma Corporation (2) · Medical University of Vienna (2) · The University of Texas Health Science Center, Houston (2) · Tanabe Pharma GmbH (1) · Washington University School of Medicine (1) · Beijing Chao Yang Hospital (1) · Second Affiliated Hospital, School of Medicine, Zhejiang University (1) · General Hospital of Shenyang Military Region (1)

Often tested with

Tested in the same studies.

Eptifibatide (1) · Heparin, Low-Molecular-Weight (1) · Enoxaparin (1) · Tissue Plasminogen Activator (1) · Warfarin (1) · Lepirudin (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test argatroban.

Studies

Open first, then newest update. How each study uses argatroban is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 23

See all 23 studies that test argatroban →

As the comparator · 2 — what is tested is compared with argatroban

Codes

What other systems call argatroban · ClinicalTrials.gg INT002967

  • MeSH (NLM) C031942argatrobanConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) IY90U61Z3SARGATROBANConfirmed FDA, NLM, Wikidata
  • RxNorm 15202One source FDA
  • Wikidata Q59400516argatroban monohydrateConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C28833ArgatrobanOne source FDA

Also registered as argatroban anhydrous (UNII OCY3U280Y3 · RxNorm 1546207), argatroban anhydrous, (21r)- (UNII 0DW7MIH1VX · RxNorm 15202), argatroban anhydrous, (21s)- (UNII 4YBM839JAC) and argatroban, (21r)- (UNII 88X69347Z5).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.